Company Overview and News

0
Third suitor joins tussle for New York Plaza Hotel

2018-07-02 thestar.com.my
Target of tussle: The Plaza Hotel stands in Midtown Manhattan in New York City. Prince Al-Waleed and Ashkenazy Acquisition have sued Sahara US Corp in May for allegedly reneging on an agreement that gives them the right to match another offer. — AFP
AC

0
New York's Plaza Hotel Has Third Suitor Join Battle for Control - Bloomberg

2018-06-30 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AC

0
France’s Accor to Buy Half of SBE Entertainment Group - WSJ

2018-06-28 wsj
French hospitality company Accor SA will take a 50% stake in hotelier Sam Nazarian’s SBE Entertainment Group, according to a person familiar with the matter, an investment valued at $319 million.
AC

62
3 Potential Silver Bullets for Playing Flighty Airline Stocks

2018-06-08 investorplace
These two diametrically opposed headlines the Financial Times ran over the past 12 days tell you all you need to know about the state of airline stocks at the moment.
MAR PAC CHDN BOE AC BA LUV MAR.WI

0
Air France's New Contender for Losing His Shirt - Bloomberg

2018-06-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
EZJ AFRAF RYAOF AC EJTTF RYAAY ESYJY AFLYY

0
New York's Storied Plaza Hotel Is Set to Sell for $600 Million - Bloomberg

2018-05-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AC

80
Prince Alwaleed's firm sells Movenpick Hotels to AccorHotels

2018-04-30 channelnewsasia
Prince Alwaleed bin Talal's Kingdom Holding and its partners have agreed to sell Movenpick Hotels and Resorts to its associate firm AccorHotels .
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP AC C.PRU C.PRS

80
Prince Alwaleed's firm sells Movenpick Hotels to AccorHotels

2018-04-30 reuters
DUBAI (Reuters) - Prince Alwaleed bin Talal’s Kingdom Holding 4280.SE and its partners have agreed to sell Movenpick Hotels and Resorts to its associate firm AccorHotels (ACCP.PA).
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP AC C.PRU C.PRS

78
China's Ctrip would welcome chance to list at home via depositary receipts -CEO

2018-04-20 reuters
SHANGHAI, April 20 (Reuters) - Ctrip.Com International Ltd , Asia’s biggest online travel firm, would welcome the chance to list at home in mainland China should regulators introduce depositary receipts as planned, Chief Executive Jane Sun told Reuters on Friday.
BABA AC

0
Ctrip signs MOU with AccorHotels

2018-04-20 globenewswire
SHANGHAI, April 20, 2018 (GLOBE NEWSWIRE) -- Ctrip.com International, Ltd. (Nasdaq:CTRP), a leading provider of accommodation reservation, transportation ticketing, package tour and corporate travel management and other travel-related services in China (“Ctrip”), announced that it has entered into a memorandum of understanding regarding its partnership with world-leading travel & lifestyle group and digital innovator AccorHotels.
AC

4
Keck Seng to subscribe to A2I shares

2018-04-19 thestar.com.my
The proceeds received by A2I from the subscription will be used to buy part of the shares to be issued by AccorInvest Group SA, the owner and operator of close to 900 hotels in Europe.
3476 AC BSMAF 1818

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:AC / ACCOR on message board site Silicon Investor.

SpaceX CFZ E-Wiggle Workspace
Hurricanes: Tracking and Economics Madrigal Pharmaceuticals
Just the Facts, Mau0027am: A Compendium of Liberal Fiction Space and Space Exploration
Guns - Americau0027s Greatest Legacy Heart Attacks, Cancer and strokes. Preventative approaches
Regeneron Pharmaceuticals Facebook, Inc.